CD44 and Miyoshi myopathy: Subsequently, the preserved adhesion molecules (e.g., CD44 and CD147) on the engineered membrane facilitate specific recognition and uptake by MM cells, thereby enhancing intracellular drug delivery and minimizing off-target effects.